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Abstract
Background: Single nucleotide polymorphisms (SNPs) in microRNA-coding genes may participate in the process of
carcinogenesis by altering the expression of tumor-related microRNAs. It has been suggested that two common SNPs
rs2910164 in miR-146a and rs11614913 in miR-196a2 are associated with susceptibility to hepatocellular carcinoma (HCC).
However, published results are inconsistent and inconclusive. In the present study, we performed a meta-analysis to
systematically summarize the possible association between the two SNPs and the risk for HCC.
Methodology/Principal Findings: We conducted a search of case-control studies on the associations of SNPs rs2910164
and/or rs11614913 with susceptibility to HCC in PubMed, EMBASE, ISI Web of Science, Cochrane Central Register of
Controlled Trials, ScienceDirect, Wiley Online Library and Chinese National Knowledge Infrastructure databases. Data from
eligible studies were extracted for meta-analysis. HCC risk associated with the two polymorphisms was estimated by pooled
odds ratios (ORs) and 95% confidence intervals (95% CIs). 5 studies on rs2910164 and 4 studies on rs11614913 were
included in our meta-analysis. Our results showed that neither allele frequency nor genotype distribution of the two
polymorphisms was associated with risk for HCC in all genetic models. Similarly, subgroup analysis in Chinese population
showed no association between the two SNPs and the susceptibility to HCC.
Conclusions/Significance: This meta-analysis suggests that two common SNPs rs2910164 and rs11614913 are not
associated with the risk of HCC. Well-designed studies with larger sample size and more ethnic groups are required to
further validate the results.
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Introduction
Primary liver cancer is the sixth most common cancer worldwide
(748,300 new cases per year). Due to its poor prognosis and high
fatality rates, the incidence and mortality rates are almost equal.
Primarylivercancercauses695,900deathseveryyear,makingitthe
third most common cause of cancer-related deaths [1]. Hepatocel-
lular carcinoma (HCC), which represents the dominant histological
type, accounts for 70–85% of primary malignancies in liver [2].
Epidemiological survey suggests that East and South-East Asia and
MiddleandWesternAfricahavethehighestprevalenceofHCCwith
almosthalfofthenewcasesanddeathsinChina[3].Althoughchronic
infectionofhepatitisBvirusandhepatitisCvirusareconsideredasthe
majorriskfactorsofHCC,theetiologyofHCCisstillyettobeclarified
[4]. Current studies indicated genetic factors may also contribute to
the etiology of HCC [5].
MicroRNAs (miRNAs) are small non-coding, single-stranded
RNA molecules with typical length of ,22 nucleotides. Function-
ing as post-transcriptional regulators, miRNAs complementarily
bind to target mRNAs and negatively regulate their stability and
transcriptional efficiency [6]. Numerous studies have demonstrat-
ed that alteration of miRNAs may play an important role in the
pathogenesis of HCC [7]. Genetic alterations of miRNAs may
have distinguished significance in HCC initiation and progression
since one single miRNA may have hundreds of gene targets. Even
a slight variation in the function or expression of a miRNA may
affect a wide spectrum of mRNA targets including many
oncogenes and tumor suppressor genes [8].
Single nucleotide polymorphisms (SNPs) in miRNA-coding
genes may have effects on either the expression or the function
of miRNAs by altering the secondary structure of miRNA
precursors, consequently leading to the aberrant expression of
a series of target genes and contributing to cancer susceptibility
[9]. Studies on the associations between SNPs in miRNAs and
human cancer have provided new insights into the molecular
mechanisms of cancer development. To date, several groups
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rs11614913 in miR-196a2 could be the biomarkers of suscep-
tibility to HCC [10–17]. However, the associations observed
between miR-146a rs2910164 and miR-196a2 rs11614913
polymorphisms and the risk for HCC are controversial and
inconclusive. Since the relatively small sample size of a single
study may not have enough power to detect slight effects of
these SNPs on HCC, meta-analysis may provide more credible
evidence by systematically summarizing existed data. Although
several meta-analyses have reported associations between the
two common SNPs and susceptibility to various cancers [18–
25], the clinical heterogeneity between the included studies on
cancers from diverse histological natures may limit the reliability
of the conclusions. Moreover, these meta-analyses did not
include all of eligible studies on HCC, thus may limit the
efficacy of detecting potential associations between the two
SNPs and HCC risk. In the present study, we conducted a meta-
analysis in order to derive more precise and comprehensive
estimation of the associations between the SNPs miR-146a
rs2910164 and miR-196a2 rs11614913 and susceptibility to
HCC.
Methods
Searching
We carried out a publication search in PubMed, EMBASE, ISI
Web of Science, Cochrane Central Register of Controlled Trials,
ScienceDirect, Wiley Online Library and Chinese National
Knowledge Infrastructure (CNKI) databases with the following
search terms: (miR-146a OR miR-196a2 OR rs2910164 OR
rs11614913) AND (hepatocellular carcinoma OR liver cancer OR
hepatoma), by two independent investigators (Zhongxia Wang and
Yin Cao, last search update: May 14, 2012). Publication date and
publication language were not restricted in our search. Reference
lists were examined manually to further identify potentially
relevant studies. We contacted the corresponding authors of
conference abstracts without sufficient data for additional in-
formation by e-mail. If no reply or the author refused to provide
the data required in this meta-analysis, the study was excluded. All
studies matching the inclusion criteria were retrieved for further
examination and data extraction. Investigators include experts in
hepatobiliary surgery, biologists and qualified graduate research-
ers. All of the investigators have received training in literature
search, statistics and evidence-based medicine.
Selection
Studies included in our meta-analysis had to meet all the
following criteria: (1)evaluated the associations between the
SNPs miR-146a rs2910164 and/or miR-196a2 rs11614913 and
susceptibility to HCC, (2) studied on human beings, (3)in a case-
control design, (4)detailed genotype data were provided for the
calculation of odds ratio (OR) and 95% confidence interval
(95% CI), (5)if serial studies of the same population from the
same group were reported, the latest study was included. We
assessed the methodological qualities of included studies by the
description of study population, detailed genotyping methods,
the set of controls and cases and related statistical methods.
Included studies had to meet the following criteria regarding
methodology: (1) participants recruited from comparable
populations with similar demographic background in control
and case groups, (2) proper diagnostic criteria to determine the
disease status, (3) Hardy-Weinberg equilibrium (HWE) reached
in control population, (4) proper method to determine the
genotypes with detailed description of method used, (5)
appropriate statistical analysis performed, (6) detailed allele
and genotype frequencies reported.
Data Abstraction
Two investigators (Zhongxia Wang and Yin Cao) independently
extracted data from the included studies. Data extracted from
eligible studies included the first author’s name, publication date,
country origin, ethnicity, genotyping method, total numbers of
cases and controls and genotype frequencies of cases and controls.
The two investigators checked the data extraction results and
reached consensus on all of the data extracted. If different results
were generated, they would check the data and have a discussion
to come to an agreement. Three senior investigators (Yitao Ding,
Chunping Jiang and Guang Yang) were invited to the discussion if
disagreement still existed.
Quantitative Data Synthesis
For each study, HWE was evaluated using the goodness-of-fit
chi-square test. P,0.05 was considered representative of a de-
parture from HWE. ORs and 95% CIs were calculated to assess
the strength of the association between miR-146a rs2910164 or
miR-196a2 rs11614913 polymorphism and susceptibility to HCC.
Pooled ORs were calculated for allele frequency comparison (miR-
146a rs2910164: C versus G, miR-196a2 rs11614913: C versus T),
additive model (miR-146a rs2910164: GC versus GG, CC versus
GG, and miR-196a2 rs11614913: TC versus TT, CC versus TT),
dominant model (miR-146a rs2910164: GC/CC versus GG, and
miR-196a2 rs11614913: TC/CC versus TT), and recessive model
(miR-146a rs2910164: CC versus GC/GG, and miR-196a2
rs11614913: CC versus TC/TT), respectively. The significance
of pooled ORs was determined by Z-test and P,0.05 was
considered as statistically significant. Statistical heterogeneity
among the studies was checked by chi-square-based Q-test. A P-
value greater than 0.10 for Q-test indicates no significant
heterogeneity existed among studies [26], so that the pooled OR
was estimated by the fixed-effects model (the Mantel-Haenszel
method) [27]; otherwise, if the heterogeneity was significant, the
random-effects model (the DerSimonian and Laird method) was
employed [28]. Sensitivity analysis was carried out by deleting one
single study each time to examine the influence of individual data
set on the pooled ORs. Publication bias of literatures was assessed
using funnel plots and Egger’s test. An asymmetric plot suggests
a possible publication bias and the P value of Egger’s test less than
0.05 was considered representative of statistically significant
publication bias [29]. All of the statistical tests were performed
with STATA software version 11.0 (STATA Corporation, College
Station, TX, USA).
Results
Study Characteristics
A total of 367 articles were retrieved after first search in
PubMed, EMBASE, ISI Web of Science, Cochrane Central
Register of Controlled Trials, ScienceDirect, Wiley Online
Library and CNKI databases. As shown in Figure 1, after our
selection, 8 case-control studies fulfilled the inclusion criteria [10–
17]. The qualities of the studies were considered acceptable for our
meta-analysis. Characteristics of included studies are summarized
in Table 1. In the study from Zhang et al. [17], genotype
frequencies of miR-146a rs2910164 and miR-196a2 rs11614913
were presented separately, so that data of each SNP were
extracted separately for meta-analysis. Therefore, a total of 5
studies [10–13,17] involving 1,912 cases and 2,149 controls for
miR-146a rs2910164 and 4 studies [14–17] involving 1,790 cases
Gene Polymorphisms and Hepatocellular Carcinoma
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analyzed in our meta-analysis. For miR-146a rs2910164, 4 studies
[11–13,17] were carried out in Asian population (Chinese
population) while 1 study [10] was from Turkish population. As
for miR-196a2 rs11614913, there were 3 studies [15–17] on
Asians (Chinese population) and 1 study [14]_ENREF_14 on
Turkish population. Several genotyping methods were employed
in the studies including polymerase chain reaction-restriction
fragment length polymorphism (PCR-RFLP), polymerase chain
reaction-ligation detection reaction (PCR-LDR) and polymerase
chain reaction-primer introduced restriction analysis (PCR-PIRA).
The genotypes distribution in the controls was in agreement with
HWE in all of the included studies. MOOSE checklist was
generated to provide detailed description of this meta-analysis
(Table S1).
Meta-analysis of the Association between miR-146a
rs2910164 Polymorphism and Susceptibility to HCC
The association between miR-146a rs2910164 polymorphism
and susceptibility to HCC was analyzed in five independent
studies with 1,912 cases and 2,149 controls. Results of the meta-
analysis are shown in Table 2. Q-test in all of the genetic models
showed no significant heterogeneity. Therefore, the pooled ORs
were calculated using fixed-effects model. No significant associa-
tion between miR-146a rs2910164 polymorphism and suscepti-
bility to HCC was identified in any of the genetic models (C versus
G: OR=0.932, 95% CI 0.851–1.022, P=0.135; GC versus GG:
OR=0.954, 95% CI 0.804–1.133, P=0.592; CC versus GG:
OR=0.850, 95% CI 0.701–1.031, P=0.098; GC/CC versus GG:
OR=0.925, 95% CI 0.787–1.087, P=0.344; CC versus GC/GG:
OR=0.904, 95% CI 0.788–1.037, P=0.150).
Four out of the five included studies were conducted in Chinese
population. In ethnicity subgroup analysis, no association was
found to be statistical significant in Chinese population in any
genetic model (C versus G: OR=0.920, 95% CI 0.836–1.012,
P=0.088; GC versus GG: OR=0.911, 95% CI 0.754–1.101,
P=0.336; CC versus GG: OR=0.845, 95% CI 0.693–1.029,
P=0.095; GC/CC versus GG: OR=0.883, 95% CI 0.739–1.056,
P=0.173; CC versus GC/GG: OR=0.904, 95% CI 0.786–1.039,
P=0.155) (Table 2).
Meta-analysis of the Association between miR-196a2
rs11614913 Polymorphism and Susceptibility to HCC
4 studies involving 1,790 cases and 1,635 controls were
assessed for the association between miR-196a2 rs11614913
polymorphism and HCC risk. Significant statistical heterogene-
ity was identified in the comparison of allele frequency, TC
versus TT, CC versus TT and in the dominant model so that
random-effects model was used in these models. Fixed-effects
model was used in the recessive model. However, for
rs11614913, none of the genetic models produced significant
association between rs11614913 polymorphism and HCC risk
(C versus T: OR=1.149, 95% CI 0.937–1.409, P=0.182; TC
versus TT: OR=1.121, 95% CI 0.855–1.470, P=0.408; CC
versus TT: OR=1.318, 95% CI 0.881–1.974, P=0.180; TC/
CC versus TT: OR=1.200, 95% CI 0.874–1.647, P=0.260;
CC versus TC/TT: OR=1.132, 95% CI 0.965–1.326,
P=0.127). The results are summarized in Table 3.
Similarly, subgroup analysis in Chinese population showed no
significant association between SNP rs11614913 and susceptibility
to HCC in Chinese population (C versus T: OR=1.064, 95% CI
0.886–1.278, P=0.508; TC versus TT: OR=0.998, 95% CI
0.844–1.179, P=0.978; CC versus TT: OR=1.124, 95% CI
0.796–1.588, P=0.507; TC/CC versus TT: OR=1.065, 95% CI
0.812–1.396, P=0.651; CC versus TC/TT: OR=1.074, 95% CI
0.905–1.275, P=0.413)(Table 3).
Figure 1. Flow diagram of study identification.
doi:10.1371/journal.pone.0040039.g001
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Funnel plot and Egger’s test were performed to assess the
publication bias of the literature. Symmetrical funnel plots were
obtained in both of the SNPs tested in all of the models. Egger’s
test further confirmed the absence of publication bias in this meta-
analysis (P.0.05).
Sensitivity Analysis
Every single study involved in this meta-analysis was deleted
each time to examine the influence of the individual data set to the
pooled ORs. For rs2910164, the study from Zhang et al. [17]
showed significant effect on the pooled OR. After exclusion of this
study in the genotype comparison of CC versus GG, the
heterogeneity test remained negative, however, pooled OR
changed from 0.850 (95% CI 0.701–1.031, P=0.10) to 0.709
(95% CI 0.539–0.931, P=0.01)(Figure 2), indicating the study
from Zhang et al. may have a major influence on the estimation of
the potential association. To explore possible factors that may
influence the stability of this comparison, we conducted stratified
analysis by HBV infection status, which is a well-known
predisposing factor of HCC [4], in control populations. With
HBV negative controls, the pooled OR was 0.957 (95% CI 0.767–
1.195, P=0.70), indicating no significant difference of susceptibil-
ity to HCC between CC and GG genotypes. Similarly, synthesis of
the data with HBV positive control population obtained a pooled
OR without statistical significance (OR=0.855, 95% CI 0.550–
1.330, P=0.49). The consistency of the stratified analysis suggests
that HBV infection status in control populations may not be the
factor that affected the stability of the comparison between CC
and GG genotypes. Caution should be made when interpreting
the result of the comparison between CC and GG genotype.
Discussion
The research on miRNAs has led to novel insights into the
molecular mechanism of HCC [30]_ENREF_22. Since each
miRNA may have hundreds of target genes, even a minor
inherited variation in miRNAs could have profound impact on the
expression of numerous genes including oncogenes and tumor
suppressor genes, thus contributes to individual’s susceptibility to
Table 1. Characteristics of studies included in the meta-analysis.
Author Year Country Ethnicity SNP
Genotyping
methods
No.(cases/
controls) HWE{
rs2910164/rs11614913
Case(%)
rs2910164/rs11614913
Control(%)
GG/TT GC/TC CC/CC GG/TT GC/TC CC/CC
Akkiz 2011 Turkey Caucasian rs2910164 PCR-RFLP 222/222 0.384 137(61.7) 75(33.8) 10(4.5) 144(64.9) 67(30.1) 11(5.0)
Xiang 2012 China Asian rs2910164 PCR-RFLP 100/100 0.506 27(27.0) 45(45.0) 28(28.0) 21(21.0) 46(46.0) 33(33.0)
Xu 2008 China Asian rs2910164 PCR-RFLP 479/504 0.119 80(16.7) 241(50.3) 158(33.0) 58(11.5) 249(48.4) 197(39.1)
Zhou 2011 China Asian rs2910164 PCR-RFLP 186/483 0.056 33(17.7) 86(46.2) 67(36.0) 71(14.7) 254(52.6) 158(32.7)
Akkiz 2011 Turkey Caucasian rs11614913 PCR-RFLP 185/185 0.492 22(11.9) 86(46.5) 77(41.6) 40(21.6) 87(47.0) 58(31.4)
Li 2010 China Asian rs11614913 PCR-RFLP 310/222 0.402 82(26.4) 150(48.4) 78(25.2) 78(35.1) 102(46.0) 42(18.9)
Qi 2010 China Asian rs11614913 PCR-LDR 361/391 0.869 100(27.7) 179(49.6) 82(22.7) 102(26.1) 197(50.4) 92(23.5)
Zhang 2011 China Asian rs2910164 PCR-PIRA 925/840 0.149 156(16.9) 450(48.6) 319(34.5) 151(18.0) 386(45.9) 303(36.1)
rs11614913 PCR-PIRA 934/837 0.972 277(29.6) 449(48.1) 208(22.3) 239(28.6) 417(49.8) 181(21.6)
{Hardy-Weinberg equilibrium (HWE) was evaluated using the goodness-of-fit chi-square test. P values were presented. P,0.05 was considered representative of
a departure from HWE. SNP, single nucleotide polymorphism.
doi:10.1371/journal.pone.0040039.t001
Table 2. Summary of pooled ORs in the meta-analysis of SNP
rs2910164.
Genetic Model Population Pooled OR [95% CI] PP h
{
C versus G Overall 0.932 [0.851–1.022] 0.135 0.212
Chinese 0.920 [0.836–1.012] 0.088 0.178
GC versus GG Overall 0.954 [0.804–1.133] 0.592 0.152
Chinese 0.911 [0.754–1.101] 0.336 0.142
CC versus GG Overall 0.850 [0.701–1.031] 0.098 0.218
Chinese 0.845 [0.693–1.029] 0.095 0.128
Dominant Overall 0.925 [0.787–1.087] 0.344 0.119
GC/CC versus GG Chinese 0.883 [0.739–1.056] 0.173 0.116
Recessive Overall 0.904 [0.788–1.037] 0.150 0.450
CC versus GC/GG Chinese 0.904 [0.786–1.039] 0.155 0.297
{Ph, P-value for heterogeneity test. OR, odds ratio; CI, confidence interval.
doi:10.1371/journal.pone.0040039.t002
Table 3. Summary of polled Ors in the meta-analysis of SNP
rs11614913.
Genetic Model Population Pooled OR [95% CI] PP h
{
C versus T Overall 1.149 [0.937–1.409] 0.182
{ 0.010
Chinese 1.064 [0.886–1.278] 0.508
{ 0.061
TC versus TT Overall 1.121 [0.855–1.470] 0.408
{ 0.079
Chinese 0.998 [0.844–1.179] 0.978 0.188
CC versus TT Overall 1.318 [0.881–1.974] 0.180
{ 0.012
Chinese 1.124 [0.796–1.588] 0.507
{ 0.081
Dominant Overall 1.200 [0.874–1.647] 0.260
{ 0.015
TC/CC versus TT Chinese 1.065 [0.812–1.396] 0.651
{ 0.080
Recessive Overall 1.132 [0.965–1.326] 0.127 0.175
CC versus TC/TT Chinese 1.074 [0.905–1.275] 0.413 0.301
{Ph, P-value for heterogeneity test.
{Random-effects model was used when the p-value for heterogeneity test
#0.10, otherwise the fixed-effect model was used. OR, odds ratio; CI, confidence
interval.
doi:10.1371/journal.pone.0040039.t003
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elucidating the role of SNPs in miRNA-coding region and their
effect on susceptibility to HCC. Current reports have revealed that
SNPs in miRNA-coding region may involve in the process of
hepatocarcinogenesis and contribute to individual susceptibility to
the development of HCC. Better understanding of the relationship
between these polymorphisms and HCC may help improve the
management of this deadly disease by the prevention and early
Figure 2. Forest plots before and after exclusion of Zhang et al’s study in the comparison between rs2910164 genotype CC and GG.
A. Before exclusion of the study from Zhang et al. B. After exclusion of Zhang et al’s study. The squares and horizontal lines correspond to the study-
specific OR and 95% CI. The area of the squares reflects the study specific weight. The diamond represents the pooled OR and 95% CI.
doi:10.1371/journal.pone.0040039.g002
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SNPs, miR-146a rs2910164 [10–13,17] and miR-196a2
rs11614913 [14–17], are indicated to be associated with suscep-
tibility to HCC. However, due to the limited sample size and the
potential bias of case selection, the associations observed are
controversial and inconclusive. In this meta-analysis, we system-
atically summarized 8 eligible case-control studies on the
association between miR-146a rs2910164 or miR-196a2
rs11614913 polymorphisms and the risk of HCC.
miR-146a rs2910164 is located in the stem region opposite to
the mature miR-146a sequence. This G.C polymorphism results
in a change from G:U pair to C:U mismatch in the stem structure
of miR-146a precursor. Several case-control studies have in-
vestigated the association between miR-146a rs2910164 poly-
morphism and risks of various cancers.[31–35] The C allele gene
displayed decreased production of mature miR-146a compared
with G allele and led to less efficient inhibition of target genes
including IL-1 receptor-associated kinase 1 (IRAK1), TNF
receptor-associated factor 6 (TRAF6) and papillary thyroid
carcinoma 1 gene (PTC1) [36]. Xu et al. showed that the G
allele represented elevation of mature miR-146a and subsequently
increased cell proliferation and colony formation [12]. More
importantly, Xu et al. first observed the association between SNP
miR-146a rs2910164 and susceptibility to HCC. However, the
results from other groups reported lack of association of miR-146a
rs2910164 and the risk for HCC [10,11,17], or only associations
between miR-146a SNP and early onset or better Child-Pugh
grade in HCC cases [13].
In this meta-analysis, a total of 5 case-control studies were
analyzed to provide a comprehensive assessment of the association
between miR-146a rs2910164 polymorphism and HCC. Our
results did not support a genetic association between rs2910164
and susceptibility to HCC. Neither allele frequency nor genotype
distribution was significantly associated with susceptibility to
HCC. Since the incidence of gene polymorphisms may vary
between different ethnic groups and this variation may interfere
with the detection of minor effect of SNPs on HCC risk, subgroup
analysis in Chinese population was performed to further explore
the potential association between rs2910164 and the risk of HCC.
However, even within the same ethnic group, no association of
statistical significance was observed. Sensitivity analysis showed
that the study from Zhang et al. [17] had a significant influence on
the pooled OR, after deleting the data set from this study, pooled
OR for CC versus GG changed from 0.85 (95% CI 0.70–1.03,
P=0.10) to 0.71 (95% CI 0.54–0.93, P=0.01). Zhang et al’s study
with a relatively large sample size may be the source of potential
heterogeneity or bias in the comparison between genotype CC and
GG and could cause a major influence on the estimation of the
association between rs2910164 polymorphism and HCC risk.
Since HBV infection is a well-established risk factor for the
development of HCC [4], HBV infection status in control
population could be the source of bias and may explain the
instability of the comparison between genotype CC and GG.
However, stratified analysis by HBV status in controls showed
consistent results suggesting no significant difference of suscepti-
bility to HCC existed between CC and GG genotypes, which
suggested HBV status may not be the main factor that influenced
the stability of this comparison. However, lack of detailed
information of both cases and controls prevented us from further
exploring the potential source of the inconsistency observed in
sensitivity analysis. In conclusion, possible association between
rs2910164 polymorphism and HCC risk should not be ruled out
and this result should be interpreted cautiously.
Another SNP shown to have potential relationship to the risk for
HCC is rs11614913 in miR-196a2. It is reported that C allele of
rs11614913 increased the expression of mature miR-196a2 in
HCC tissues [15]. Of note, several genes involved in carcinogen-
esis including homeobox (HOX) and annexin A1 (ANXA1) have
been reported to be the target of miR-196a2. HOX genes encode
important transcription factors during normal development and in
carcinogenesis [37]. The disorder of HOX proteins was suggested
to play a crucial role in hepatocarcinogenesis and the progression
of HCC [38]. Acting as a mediator of apoptosis and inhibitor of
cell proliferation, ANXA1 participates in various physiological and
pathological processes [39–42]. Masaki et al. demonstrated that
ANXA1 participated in the malignant transformation of HCC and
was closely related to the malignant behavior of HCC [43].
Therefore, alterations in miR-196a2 may contribute to suscepti-
bility to HCC through the deregulation of target genes including
HOX and ANXA1. Indeed, recent studies have reported the
association of miR-196a2 rs11614913 polymorphism with HCC
risk [14–16]. However, in another study, no association between
rs11614913 and HCC was observed [17].
4 studies on the relationship between rs11614913 and
susceptibility to HCC were included in our meta-analysis. To
our surprise, we failed to find any association between rs11614913
polymorphism and the risk for HCC in any of the examined
genetic models. Similarly, subgroup analysis in Chinese population
also showed no association of miR-196a2 rs11614913 poly-
morphism with susceptibility to HCC. Sensitivity analysis found
no significant influence of any single study on pooled ORs,
indicating the stability of this meta-analysis was acceptable.
Comparisons with other Meta-analysis
Several previous meta-analyses systematically reviewed the
potential association of the two common polymorphisms
rs2910164 and rs11614913 with susceptibility to cancer [18–25].
Two of them investigated rs2910164 in miR-146a [19,22] while
four studies focused on rs11614913 in miR-196a2 [18,21,23,25].
Meta-analyses from Tian et al [24] and Xu et al [20] covered both
of the two SNPs. These meta-analyses reported statistically
significant association between the two common SNPs and
susceptibility to cancer without pre-specified tissue origin. How-
ever, the major concern is clinical heterogeneity brought by
inherent difference between cancers from distinct tissue origins,
which may limit the reliability of the conclusions of the previous
meta-analyses. Only two meta-analyses evaluated the role of
rs2910164 and rs11614913 with pre-specified cancer type as
breast cancer [44,45]. With more studies included than previous
meta-analysis by Gao et al, Lian et al reported association between
CC homozygote of rs2910164 may contribute to breast cancer
susceptibility in Europeans which was not detected in the meta-
analysis by Gao et al, indicating insufficient data included may
limit the power of meta-analysis. To date, there is no meta-analysis
with focus on the association of rs2910164 and rs11614913 with
HCC risk. Some of the previous meta-analyses explored the
relationship between rs11614913 and HCC by means of subgroup
analysis [18,20,21,23]. Unfortunately, the results were controver-
sial across the meta-analyses which may at least partly due to the
fact that none of these meta-analyses included all available studies
concerning the association between rs11614913 and susceptibility
to HCC. With regard to rs2910164, none of the meta-analyses
performed subgroup analysis in HCC and similarly, several
association studies with eligible data were left out in their analyses.
In the present meta-analysis, with focus on HCC, we performed
comprehensive literature search in multiple databases without
limiting publication language and date and included all available
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and susceptibility to HCC. We conducted quantitative data
synthesis in allele frequency, additive model, dominant model and
recessive model and found none of the SNPs was associated with
the risk of HCC in all of the genetic models tested. Our meta-
analysis, though with limitations, concludes that there is no
significant association of rs2910164 in miR-146a and rs11614913
in miR-196a2 with susceptibility to HCC with stronger evidence
compared with previous meta-analyses.
Limitations
To the best of our knowledge, this is the first meta-analysis
evaluating the potential association between two common
polymorphisms rs2910164 in miR-146a and rs11614913 in miR-
196a2 and susceptibility to hepatocellular carcinoma. However,
caution should be made when interpreting the results due to some
limitations of this meta-analysis. Firstly, heterogeneity was
detected in some comparisons of rs11614913 and sensitivity
analysis showed that the study from Zhang et al. [17] had
a significant influence on the evaluation of potential association
between rs2910164 and the risk for HCC. Stratified analysis
showed that HBV infection status in control population was not
the cause of inconsistency of the result whereas insufficient
information prevented us from further exploring the source of the
instability. Importantly, it should be acknowledged that potential
heterogeneity and bias may distort the results from this meta-
analysis. Secondly, even after assembling the existed evidences, the
sample size is still relatively small thus may not be sufficient
enough to detect possible minor effects of miR-146a rs2910164
and miR-196a2 rs11614913 polymorphisms on susceptibility to
HCC. Thirdly, lack of available data prevented an adjustment for
subgroup factors including age, HBV/HCV infection status,
alcohol consumption and gender, etc. These factors could
influence the estimation of the slight associations between SNPs
and susceptibility to HCC by interacting with genetic factors.
Indeed, several studies report that the association of the two SNPs
with HCC risk only existed in male population [12,16]. At last, the
included studies were carried out in Asians (Chinese population)
and Caucasians (Turkish population). Absence of data from other
ethnics makes a more comprehensive evaluation of the association
between the two SNPs and susceptibility to HCC not possible.
In summary, despite the limitation, this meta-analysis suggests
that miR-146a rs2910164 and miR-196a2 rs11614913 poly-
morphisms may not be associated with the risk of HCC. Well-
designed studies with larger sample size and more ethnic groups
should be considered to further clarify the association. Moreover,
other factors such as gender, age, HBV/HCV infection status and
alcohol consumption should also be considered in future studies.
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